| Trial ID: | L1311 |
| Source ID: | NCT01269827
|
| Associated Drug: |
Pentoxifylline
|
| Title: |
Pentoxifylline and Systemic Inflammation in Hemodialysis Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Inflammation|End-stage Renal Disease|Hemodialysis
|
| Interventions: |
DRUG: Pentoxifylline|DRUG: starch tablets
|
| Outcome Measures: |
Primary: serum levels of TNF-a, IL-6 and CRP, 4 months |
|
| Sponsor/Collaborators: |
Sponsor: Coordinación de Investigación en Salud, Mexico
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
36
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2006-01
|
| Completion Date: |
2008-05
|
| Results First Posted: |
|
| Last Update Posted: |
2018-12-19
|
| Locations: |
Hospital de Especialidades, CMNO, IMSS, Guadalajara, Jalisco, 44320, Mexico
|
| URL: |
https://clinicaltrials.gov/show/NCT01269827
|
